Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.320 AlteredExpression disease BEFREE MiR-93-3p was found to be highly expressed, while ZNF667-AS1 and PEG3 were poorly expressed in CC. 31420931 2019
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.320 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.320 AlteredExpression disease BEFREE The results showed that the expression of LncRNA ZNF667-AS1 in cervical cancer was significantly lower than that in normal cervical tissues. 29243775 2017
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms
0.310 AlteredExpression group BEFREE The expression levels of ZNF667-AS1 and ZNF667 were significantly reversed by treatment with 5-Aza-dC and TSA in esophageal cancer cell lines. 31804468 2019
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.310 AlteredExpression disease BEFREE The expression levels of ZNF667-AS1 and ZNF667 were significantly reversed by treatment with 5-Aza-dC and TSA in esophageal cancer cell lines. 31804468 2019
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms
0.310 Biomarker group CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.310 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0005396
Disease: Bile Duct Neoplasms
Bile Duct Neoplasms
0.300 Biomarker group CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0007140
Disease: Carcinosarcoma
Carcinosarcoma
0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0007873
Disease: Uterine Cervical Neoplasm
Uterine Cervical Neoplasm
0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0025500
Disease: Mesothelioma
Mesothelioma
0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms
0.300 Biomarker group CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0205944
Disease: Sarcoma, Epithelioid
Sarcoma, Epithelioid
0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0205945
Disease: Sarcoma, Spindle Cell
Sarcoma, Spindle Cell
0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0740277
Disease: Bile duct carcinoma
Bile duct carcinoma
0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.300 Biomarker group CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C1708349
Disease: Hereditary Diffuse Gastric Cancer
Hereditary Diffuse Gastric Cancer
0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.300 Biomarker disease CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.300 Biomarker disease CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C1257931
Disease: Mammary Neoplasms, Human
Mammary Neoplasms, Human
0.300 Biomarker disease CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.300 Biomarker group CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C4704874
Disease: Mammary Carcinoma, Human
Mammary Carcinoma, Human
0.300 Biomarker disease CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 AlteredExpression group BEFREE Therefore, lncRNA MORT overexpression may inhibit cancer cell proliferation in OSCC cells by downregulating ROCK1. 30805944 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE Therefore, lncRNA MORT may inhibit cancer cell proliferation in prostate carcinoma by preventing glucose uptake. 31516590 2019